These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 27495899)
1. CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway. Chen J; Lv H; Hu J; Ji M; Xue N; Li C; Ma S; Zhou Q; Lin B; Li Y; Yu S; Chen X Cancer Lett; 2016 Oct; 381(2):391-403. PubMed ID: 27495899 [TBL] [Abstract][Full Text] [Related]
3. Hedgehog Signaling and Truncated GLI1 in Cancer. Doheny D; Manore SG; Wong GL; Lo HW Cells; 2020 Sep; 9(9):. PubMed ID: 32957513 [TBL] [Abstract][Full Text] [Related]
4. Identification of pseudolaric acid B as a novel Hedgehog pathway inhibitor in medulloblastoma. Wei SF; He DH; Zhang SB; Lu Y; Ye X; Fan XZ; Wang H; Wang Q; Liu YQ Biochem Pharmacol; 2021 Aug; 190():114593. PubMed ID: 33964282 [TBL] [Abstract][Full Text] [Related]
5. RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism. Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG Cancer Lett; 2019 Feb; 442():341-350. PubMed ID: 30447254 [TBL] [Abstract][Full Text] [Related]
6. Improved Safety and Anti-Glioblastoma Efficacy of CAT3-Encapsulated SMEDDS through Metabolism Modification. Wang H; Li L; Ye J; Dong W; Zhang X; Xu Y; Hu J; Wang R; Xia X; Yang Y; Jin D; Wang R; Song Z; Gao L; Liu Y Molecules; 2021 Jan; 26(2):. PubMed ID: 33477555 [TBL] [Abstract][Full Text] [Related]
7. Statins Synergize with Hedgehog Pathway Inhibitors for Treatment of Medulloblastoma. Gordon RE; Zhang L; Peri S; Kuo YM; Du F; Egleston BL; Ng JMY; Andrews AJ; Astsaturov I; Curran T; Yang ZJ Clin Cancer Res; 2018 Mar; 24(6):1375-1388. PubMed ID: 29437795 [No Abstract] [Full Text] [Related]
8. Saikosaponin B1 and Saikosaponin D inhibit tumor growth in medulloblastoma allograft mice via inhibiting the Hedgehog signaling pathway. Luo J; Wang J; Yang J; Huang W; Liu J; Tan W; Xin H J Nat Med; 2022 Jun; 76(3):584-593. PubMed ID: 35171398 [TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Structure-Activity Relationship of Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity. Lu W; Liu Y; Ma H; Zheng J; Tian S; Sun Z; Luo L; Li J; Zhang H; Yang ZJ; Zhang X ACS Chem Neurosci; 2017 Sep; 8(9):1980-1994. PubMed ID: 28618224 [TBL] [Abstract][Full Text] [Related]
11. Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold. Berardozzi S; Bernardi F; Infante P; Ingallina C; Toscano S; De Paolis E; Alfonsi R; Caimano M; Botta B; Mori M; Di Marcotullio L; Ghirga F Eur J Med Chem; 2018 Aug; 156():554-562. PubMed ID: 30025349 [TBL] [Abstract][Full Text] [Related]
12. Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1. Götschel F; Berg D; Gruber W; Bender C; Eberl M; Friedel M; Sonntag J; Rüngeler E; Hache H; Wierling C; Nietfeld W; Lehrach H; Frischauf A; Schwartz-Albiez R; Aberger F; Korf U PLoS One; 2013; 8(6):e65403. PubMed ID: 23762360 [TBL] [Abstract][Full Text] [Related]
14. mTORC1-Mediated Inhibition of 4EBP1 Is Essential for Hedgehog Signaling-Driven Translation and Medulloblastoma. Wu CC; Hou S; Orr BA; Kuo BR; Youn YH; Ong T; Roth F; Eberhart CG; Robinson GW; Solecki DJ; Taketo MM; Gilbertson RJ; Roussel MF; Han YG Dev Cell; 2017 Dec; 43(6):673-688.e5. PubMed ID: 29103956 [TBL] [Abstract][Full Text] [Related]
15. Effective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood-brain barrier. Rohner A; Spilker ME; Lam JL; Pascual B; Bartkowski D; Li QJ; Yang AH; Stevens G; Xu M; Wells PA; Planken S; Nair S; Sun S Mol Cancer Ther; 2012 Jan; 11(1):57-65. PubMed ID: 22084163 [TBL] [Abstract][Full Text] [Related]
16. MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor. Hoch L; Faure H; Roudaut H; Schoenfelder A; Mann A; Girard N; Bihannic L; Ayrault O; Petricci E; Taddei M; Rognan D; Ruat M FASEB J; 2015 May; 29(5):1817-29. PubMed ID: 25636740 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional repressor REST drives lineage stage-specific chromatin compaction at Dobson THW; Tao RH; Swaminathan J; Maegawa S; Shaik S; Bravo-Alegria J; Sharma A; Kennis B; Yang Y; Callegari K; Haltom AR; Taylor P; Kogiso M; Qi L; Khatua S; Goldman S; Lulla RR; Fangusaro J; MacDonald TJ; Li XN; Hawkins C; Rajaram V; Gopalakrishnan V Sci Signal; 2019 Jan; 12(565):. PubMed ID: 30670636 [TBL] [Abstract][Full Text] [Related]
18. Hedgehog signaling pathway is active in GBM with GLI1 mRNA expression showing a single continuous distribution rather than discrete high/low clusters. Chandra V; Das T; Gulati P; Biswas NK; Rote S; Chatterjee U; Ghosh SN; Deb S; Saha SK; Chowdhury AK; Ghosh S; Rudin CM; Mukherjee A; Basu A; Dhara S PLoS One; 2015; 10(3):e0116390. PubMed ID: 25775002 [TBL] [Abstract][Full Text] [Related]
19. MK-4101, a Potent Inhibitor of the Hedgehog Pathway, Is Highly Active against Medulloblastoma and Basal Cell Carcinoma. Filocamo G; Brunetti M; Colaceci F; Sasso R; Tanori M; Pasquali E; Alfonsi R; Mancuso M; Saran A; Lahm A; Di Marcotullio L; Steinkühler C; Pazzaglia S Mol Cancer Ther; 2016 Jun; 15(6):1177-89. PubMed ID: 26960983 [TBL] [Abstract][Full Text] [Related]
20. Jervine exhibits anticancer effects on nasopharyngeal carcinoma through promoting autophagic apoptosis via the blockage of Hedgehog signaling. Chen J; Wen B; Wang Y; Wu S; Zhang X; Gu Y; Wang Z; Wang J; Zhang W; Yong J Biomed Pharmacother; 2020 Dec; 132():110898. PubMed ID: 33113432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]